
The European Commission Thursday announced that it is giving 24.4 million euro for urgently needed Ebola research.
The funding will go to five projects, ranging from clinical trial of a potential vaccine to testing existing and novel compounds to treat Ebola, said the Commission in a statement.
The EU's executive body said it is also working with industry on the further development of vaccines, drugs and diagnostics for Ebola. The President of the European Commission, Josأ© Manuel Barroso commented: "We're in a race against time on Ebola, and we must address both the emergency situation and at the same time have a long term response." "I am therefore happy to announce that additional funding of 24.4 million euro will be made available which will speed up some of the most promising research to develop vaccines and treatments," he said.
On his part , EU Research and Science Commissioner Maire Geoghegan-Quinn said that "with the WHO bringing the international community together in Geneva today, one of the most important messages is that we need to step up medical research on Ebola."
GMT 10:31 2018 Tuesday ,13 November
Russian police uproot 70 underground drug labs in past six monthsGMT 16:32 2018 Tuesday ,06 November
Rwanda aims to achieve universal access to clean water by 2024GMT 16:57 2018 Sunday ,04 November
Palestinian women witness higher cure rate of breast cancerGMT 13:11 2018 Tuesday ,30 October
Emergency surgery saves life of touristGMT 10:44 2018 Tuesday ,23 October
Scientists find microplastics in human stool for first timeGMT 09:18 2018 Tuesday ,23 October
US judge upholds Monsanto weedkiller cancer verdict, reduces payoutGMT 14:22 2018 Friday ,19 October
Birth spacing ‘improving health of Omani women’GMT 15:40 2018 Monday ,15 October
Pakistani president launches nationwide anti-measles driveMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor